With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Please join us for an ECHO webinar on Tuesday Apr 20, 2021 (11 am – 12 pm) featuring Dr. Margaret Magdesian (CEO and Founder, Ananda Devices). Dr. Magdesian’s presentation entitled, “Scientific entrepreneurship and the need for new tools to achieve the UN sustainable development goals”, will feature an overview of Ananda Devices, its technologies and the story behind its success.
Ananda Devices is a certified Women Owned SME offering products and services for more efficient growth of human nervous system-on-a-chip. Their products enable pharmaceutical, vaccine and cosmetic industries to perform drug screening, toxicity and efficacy testing up to 50x faster and 90% more cost-effective than current technologies. Their products facilitate automation of biological tests on models of human brain, spinal cord and innervated tissue.
Register in advance for this meeting: https://us02web.zoom.us/meeting/register/tZAsfuuorz0iH9ybWINFqFA2NMI7ImUNzFQL
After registering, you will receive a confirmation email containing information about joining the webinar.
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i).